RTI Surgical Implants

RTI Surgical Implants

Cortiva® Allograft Dermis

The Cortiva Allograft Dermis implants offer three important components of a tissue-based implant: consistency* and handling, reliable supply and sterility.*

Cortiva<sup>®</sup> and Cortiva<sup>®</sup> 1mm Allograft Dermis

Overview & Features


  • Cortiva® Allograft Dermis
  • Cortiva® 1mm Allograft Dermis
  • Cortiva® 1mm Tailored Allograft Dermis
  • Cortiva Silhouette® Allograft Dermis


  • Sterilized through the Tutoplast Tissue Sterilization Process
  • Graft labeled sterile
  • Validated viral inactivation



  • The Cortiva allograft portfolio has best-in0class thickness consistency.


  • Cortiva Allograft Dermis implants rehydrate in approximately 30 seconds.
    • Results in reduced preparation time compared to some other ADMs.


  • Cortiva allograft implants are preservative and antibiotic free.


  • RTI has invested significantly in increased processing capacity and optimization to provide a consistent supply.
    • Tissue will be available where and when it is needed without delay to surgeries.


  • Cortiva Allograft Dermis is referenced in multiple publications. Most publications are head-to-head against AlloDerm and showed Cortiva allograft to be comparable to AlloDerm. 1-5

Handling Properties

  • Five-year, room-temperature shelf life — no refrigeration required

*Data on file at RTI Surgical.

**Performance data from animal models may not be representative of performance in humans.

***Clinical cases are unique and individual results may vary.

1. Rajiv P. Parikh, et al. 2018. “Cortiva versus AlloDerm ready to use in prepectoral and submuscular breast reconstruction: prospective randomized clinical trial study design and early findings.” Plastic and Reconstructive Surgery Global Open. November 2018. doi:


2. Keifer, et. al. 2016. “A complication analysis of two acellular dermal matrices in prosthetic based reconstruction.” Plastic and Reconstructive Surgery Global Open. July 2016 4(7), e800. http://doi.org/10.1097/GOX.0000000000000790

3. Moyer, et. al. 2017. “A histological comparison of two human acellular dermal matrix products in prosthetic-based breast reconstruction.” Plastic and Reconstructive Surgery Global Open, December 2017, 5(12) doi: 10.1097/GOX.0000000000001576

4. Urquia, et al. 2020. “Surgical Outcomes in Prepectoral Breast Reconstruction.” Plastic and Reconstructive Surgery Global Open. 2020;8:e2744; doi: 10.1097/GOX.0000000000002744; Published online 23 April 2020.

5. Roth J. S., Diaz D. F. Laparoscopic Paraesophageal Hernia Repair with Acellular Dermal Matrix Cruroplasty. JSLS, Journal of the Society of Laparoendoscopic Surgeons. (2011) 15:355-360.

Regulatory approvals vary by country. Therefore, we kindly ask you to contact the distributor in your region regarding availability of specific products, implants and / or instrumentation in your region.